-
1 Comment
Tianjin Lisheng Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 9.1% below its 200 day moving average.
From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
Tianjin Lisheng Pharmaceutical Co.,Ltd's total revenue sank by 44.5% to $225M since the same quarter in the previous year.
Its net income has dropped by 232.2% to $-71M since the same quarter in the previous year.
Finally, its free cash flow fell by 3500.2% to $-65M since the same quarter in the previous year.
Based on the above factors, Tianjin Lisheng Pharmaceutical Co.,Ltd gets an overall score of 1/5.
| Industry | Drug Manufacturers-Specialty & Generic |
|---|---|
| Sector | Healthcare |
| ISIN | CNE100000NJ9 |
| CurrencyCode | CNY |
| Exchange | SHE |
| Beta | 0.3 |
|---|---|
| Target Price | None |
| PE Ratio | 45.31 |
| Market Cap | 4B |
| Dividend Yield | 1.3% |
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the production and sale of chemical medicines. The company offers tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, and bulk medicines, as well as intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. It also exports its products. The company is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002393.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
